NXPL Stock Overview
Operates as a healthcare and e-commerce company in Europe, North America, South America, the Asia and Pacific, and Africa.
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 6/6 |
Dividends | 0/6 |
NextPlat Corp Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$1.19 |
52 Week High | US$3.08 |
52 Week Low | US$1.00 |
Beta | 0.93 |
11 Month Change | 1.72% |
3 Month Change | -2.07% |
1 Year Change | -55.45% |
33 Year Change | -83.10% |
5 Year Change | -95.16% |
Change since IPO | -99.99% |
Recent News & Updates
Recent updates
Shareholder Returns
NXPL | US Telecom | US Market | |
---|---|---|---|
7D | 3.0% | -3.1% | -2.9% |
1Y | -55.5% | 19.9% | 17.2% |
Return vs Industry: NXPL underperformed the US Telecom industry which returned 17.2% over the past year.
Return vs Market: NXPL underperformed the US Market which returned 19.8% over the past year.
Price Volatility
NXPL volatility | |
---|---|
NXPL Average Weekly Movement | 7.8% |
Telecom Industry Average Movement | 5.7% |
Market Average Movement | 6.0% |
10% most volatile stocks in US Market | 14.9% |
10% least volatile stocks in US Market | 2.9% |
Stable Share Price: NXPL's share price has been volatile over the past 3 months.
Volatility Over Time: NXPL's weekly volatility (8%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
n/a | 154 | Charles Fernandez | www.nextplat.com |
NextPlat Corp operates as a healthcare and e-commerce company in Europe, North America, South America, the Asia and Pacific, and Africa. The company operates full-service retail specialty services pharmacies that provides prescription pharmaceuticals prescription pharmaceuticals, third-party administration, risk and data management services, compounded medications, tele-pharmacy services, anti-retroviral medications, medication therapy management, contracted pharmacy services, and health practice risk management to healthcare organizations and providers, as well as supplies prescription medications to long-term care facilities. It also offers COVID-19 related diagnostics and vaccinations, and medication adherence packaging; and value-added services, such as prior authorization assistance, same-day home-medication delivery, on site provider consultation services, primary care reporting and analytics, and customized packaging solutions, as well as acquires and leases an e-commerce platform to collaborate with businesses to optimize their ability to sell their goods online.
NextPlat Corp Fundamentals Summary
NXPL fundamental statistics | |
---|---|
Market cap | US$22.70m |
Earnings (TTM) | -US$4.07m |
Revenue (TTM) | US$52.37m |
0.4x
P/S Ratio-5.5x
P/E RatioIs NXPL overvalued?
See Fair Value and valuation analysisEarnings & Revenue
NXPL income statement (TTM) | |
---|---|
Revenue | US$52.37m |
Cost of Revenue | US$37.01m |
Gross Profit | US$15.37m |
Other Expenses | US$19.44m |
Earnings | -US$4.07m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | -0.22 |
Gross Margin | 29.34% |
Net Profit Margin | -7.78% |
Debt/Equity Ratio | 3.1% |
How did NXPL perform over the long term?
See historical performance and comparison